6h
Bizcommunity on MSNSanofi-Novavax deal in jeopardy as FDA halts vaccine approvalDr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
9h
Investor's Business Daily on MSNBiotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Continuing to ask questions on an issue that has been answered multiple times, by multiple people, introduces doubt and anxiety. Our children deserve better.
Strokes caused by an artery tear are landing five times as many Americans in the hospital these days, a new study says.
Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.
Medical researchers helped tame a worldwide pandemic, but they may be powerless against the financial disease rapidly ...
Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...
Dr. Marks was asked to leave and then subsequently wrote that he did not want to become “subservient to [Secretary Kennedy’s] misinformation and lies.” Peter Marks is not a hero of the resistance but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results